Pharmacovigilance study of GLP-1 receptor agonists for metabolic and nutritional adverse events

• Päätekijät: Long He (Tekijä), Qiuyu Li (Tekijä), Yongfeng Yang (Tekijä), Jiahao Li (Tekijä), Wei Luo (Tekijä), Yilan Huang (Tekijä), Xiaoyan Zhong (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Aims: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are employed extensively in the management of type 2 diabetes and obesity. However, there is a paucity of real-world data on their safety and tolerability for metabolic and nutritional adverse events in large sample populations. This study...